Skip to main content
Caplight Logo









Hangzhou Dessight Biomedical Co., Ltd.

Hangzhou Dessight Biomedical Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://dessight.cn

Last Round

Series A

Jun 16, 2025

Total Funding Raised

$14M

Company Overview

Hangzhou Dessight Biomedical Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series A round in June 2025.

Hangzhou Dessight Biomedical Co., Ltd. is a medical technology company that develops ophthalmic and microsurgical robotic systems designed for high-precision surgical procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hangzhou Dessight Biomedical Co., Ltd. Comparables

Compare Hangzhou Dessight Biomedical Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Dessight Biomedical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Guangzhou Oculotronics Medical Equipment Co., Ltd.
89%
ForSight Robotics
85%
Horizon Surgical Systems
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hangzhou Dessight Biomedical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 16, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Hangzhou Dessight Biomedical Co., Ltd. Investors

Notable investors and investment history

Hangzhou Dessight Biomedical Co., Ltd. investors
InvestorRounds
Panlin CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2025

    $14M round led by Panlin Capital.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hangzhou Dessight Biomedical Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Hangzhou Dessight Biomedical Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hangzhou Dessight Biomedical Co., Ltd.'s valuation, stock price, and market status.

Is Hangzhou Dessight Biomedical Co., Ltd. a public or private company?

Hangzhou Dessight Biomedical Co., Ltd. is a private company.

What is the current stock price of Hangzhou Dessight Biomedical Co., Ltd.?

Hangzhou Dessight Biomedical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Dessight Biomedical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hangzhou Dessight Biomedical Co., Ltd. worth (valuation)?

Valuation information for Hangzhou Dessight Biomedical Co., Ltd. is not publicly available.

Can I buy Hangzhou Dessight Biomedical Co., Ltd. stock?

Hangzhou Dessight Biomedical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hangzhou Dessight Biomedical Co., Ltd.'s last funding round?

Hangzhou Dessight Biomedical Co., Ltd.'s most recent funding round was Series A on June 16, 2025.

Who are the main investors in Hangzhou Dessight Biomedical Co., Ltd.?

Key investors in Hangzhou Dessight Biomedical Co., Ltd. include Panlin Capital.

Will Hangzhou Dessight Biomedical Co., Ltd. IPO soon?

No public IPO plans have been announced for Hangzhou Dessight Biomedical Co., Ltd..

How can I track Hangzhou Dessight Biomedical Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Hangzhou Dessight Biomedical Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersHangzhou
Year Founded2021
Last FundingJun 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?